Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,56116,580 of 20,252 grants

Active OTHER RESEARCH-RELATED
Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Project Summary Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of cancer treatment drugs that often presents as debilitating pain in a stoc...

$2.82M
USD
Active NON-SBIR/STTR RPGS
Germline and Somatic Genomic Studies in CLL Minorities
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

African Americans are significantly underrepresented in cancer research.Although there have been recent efforts toward more inclusion of African Americans in cancer research, subst...

$6.77M
USD
Active OTHER RESEARCH-RELATED
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY Immune checkpoint inhibitors (ICIs) provide durable clinical responses in about 20% of cancer patients, but have minimal effects in cancers lacking intra?tumoral T...

$2.22M
USD
Completed OTHER RESEARCH-RELATED
Investigating apoptotic priming as a determinant of sensitivity to leukemia-directed therapies
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is a lethal blood cancer characterized by a clonal expansion of precursor blood- forming cells. Intensive chemotherapy has bee...

$2.55M
USD
Completed OTHER RESEARCH-RELATED
Understanding drug delivery through an integrated barcoding approach
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2021 – 2023

Project Summary Despite being hailed as the ?magic bullet? that would selectively target and cure cancer, only a handful of nanoparticles have been successfully translated to the c...

$1.54M
USD
Completed OTHER RESEARCH-RELATED
Dissecting the oncogenic and pro-metastatic roles of PTHLH-mediated calcium signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2023

PROJECT SUMMARY Pancreatic cancer is a major health issue in the US, with only 7% of patients surviving beyond 5-years and nearly all patients presenting with metastases.Identifyin...

$1.37M
USD
Active OTHER RESEARCH-RELATED
Targeting an unrecognized checkpoint on T cell function in tumors
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT A diverse accumulation of infiltrating immune cells is a prominent feature of nearly all cancers1.By directing the effector functions of cancer-killing T c...

$2.41M
USD
Active OTHER RESEARCH-RELATED
Chromosomal Instability as a Marker and Mechanism of Radiation Response
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

ABSTRACT Human Papilloma Virus (HPV) causes nearly 5% of all cancers worldwide and is implicated in 95% of cervical and 70% of oropharyngeal cancers (OPC).Curative platinum-based c...

$1.85M
USD
Active NON-SBIR/STTR RPGS
Low Cost Tethered Capsule Endoscope with High-Resolution Digital Chromoscopy for Barrett's Screening
NATIONAL CANCER INSTITUTE Rice University United States 2021 – 2026

Abstract Esophageal cancer is the 6th leading cause of cancer death worldwide; rates of esophageal adenocarcinoma (EAC) have risen exponentially over the past 4 decades. When EAC i...

$6.58M
USD
Active NON-SBIR/STTR RPGS
Mechanisms associated with organotropic metastasis
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

ABSTRACT Most cancer patients with solid tumors die of metastatic disease and organotropic spread is an understudied aspect of metastasis, for which new insights are urgently requi...

$5.1M
USD
Active NON-SBIR/STTR RPGS
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

ABSTRACT Acute myeloid leukemias (AMLs) are a genetically heterogeneous group of clonal hematopoietic disorders characterized by accumulation of immature non-lymphoid marrow progen...

$3.64M
USD
Active NON-SBIR/STTR RPGS
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Mayo Clinic Jacksonville United States 2021 – 2026

Project Abstract Lung cancer is the number one cause of cancer death in the United States.Non-small cell lung cancer (NSCLC), which accounts for the majority (80%) of lung cancer d...

$3.58M
USD
Active NON-SBIR/STTR RPGS
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

SUMMARY.Kinase inhibitors targeting the catalytic subunit of the DNA-dependent protein kinase (DNAPKcs) are being developed to sensitize tumors to clastogenic (chromosomal-breaking...

$4.03M
USD
Completed NON-SBIR/STTR RPGS
Dynamic prediction incorporating time-varying covariates for the onset of breast cancer
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2025

PROJECT SUMMARY Accurate assessment of risk is a top priority in oncology due to the population burden of cancer.Breast cancer is the leading cancer diagnosis among women worldwide...

$3.6M
USD
Active NON-SBIR/STTR RPGS
Genetic dissection of oncogenic Kras signaling
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

ABSTRACT Lung cancer is a prevalent cancer type that leads to more deaths than the next four major cancer types combined. KRAS is one of the most frequent oncogenes in human lung c...

$4.68M
USD
Active NON-SBIR/STTR RPGS
THE ROLE OF SELENOPROTEIN SYNTHESIS PATHWAY IN ACUTE MYELOID LEUKEMIA
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

AML is the most common acute leukemia in adults, and it appears increasingly with age.Despite overall improvement in the treatment of leukemia, AML still carries a devastating prog...

$4.65M
USD
Completed TRAINING, INDIVIDUAL
Elucidating the molecular mechanisms of PRMT5i response and resistance in LUAD and PDAC
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2021 – 2024

Project Summary Protein arginine methyltransferase 5 (PRMT5) is part of a methyltransferase complex that symmetrically dimethylates arginine residues in a wide range of proteins re...

$663.9K
USD
Completed TRAINING, INDIVIDUAL
The role of an invasive phenotype in promoting resistance to MAPK-directed therapies in thyroid cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2023

Thyroid cancer is the most common endocrine malignancy, accounting for over 52,000 new diagnoses each year.Advanced papillary thyroid cancer (PTC) and anaplastic thyroid cancer (AT...

$340.8K
USD
Completed TRAINING, INDIVIDUAL
The Effect of Tumor Burden on Peripheral cDC1 Activation and Functionality
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Tumors disrupt the homeostasis of the immune system, altering immune cell composition and phenotype in the tumor microenvironment (TME), lymph nodes, splee...

$377.4K
USD
Completed NON-SBIR/STTR RPGS
Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2025

PROJECT SUMMARY / ABSTRACT Following treatment for early-stage cancer, most survivors fear the possibility of a recurrence.While mild and intermittent for many, these fears become...

$6.55M
USD